First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer. Invest New Drugs. 2021 10; 39(5):1348-1356.